A new drug for bladder cancer

by Medindia Content Team on  May 23, 2002 at 3:23 PM General Health News
RSS Email Print This Page Comment bookmark
Font : A-A+

A new drug for bladder cancer
Researchers at the Hopkins University at Texas, have enrolled 10 patients with early stage bladder cancer to a trial of the drug gemcitabine. A drug which is used for pancreatic and non-small cell lung cancer may also be applicable to bladder cancer. They administered it directly into the bladder, through a tube, and found that little of it escaped into the bloodstream.

This might be why there were few, if any, side effects linked to gemcitabine in this trial. Standard treatments for bladder cancer cause a number of adverse effects such as fever, pain on urination and reduced white blood cell counts. Gemcitabine works by blocking the growth of cancer cells. The scene is now set for larger trials of the new drug, which may offer much needed hope to those who have bladder cancer.


Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Cancer and Homeopathy Clinical Trials - Different Phases of the trial Vesico-Ureteric Reflux Causing UTI in Children Enuresis/Bedwetting Signature Drug Toxicity Cancer Facts Cancer Interstitial Cystitis Bladder Cancer 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive

Loading...